Intravenous versus Oral Busulfan-Based Conditioning for Pediatric Allogeneic Hematopoietic Cell Transplantations: Did The Pendulum Swing Too Far, Too Fast?

被引：4

作者：

Bredeson, Christopher ^{[1
,2
]}

机构：

[1] Ottawa Hosp, Blood & Marrow Transplant Program, Ottawa, ON, Canada

[2] Ottawa Hosp Res Inst, Ottawa, ON, Canada

来源：

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2013年 / 19卷 / 12期

关键词：

BONE-MARROW-TRANSPLANTATION; CYCLOPHOSPHAMIDE; LEUKEMIA; TOXICITY; THERAPY;

D O I：

10.1016/j.bbmt.2013.10.008

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1657 / 1658

页数：2

共 13 条

[1] Acute safety and pharmacokinetics of intravenous busulfan when used with oval busulfan and cyclophosphamide as pretransplantation conditioning therapy: A phase I study [J].

Andersson, BS ;

Madden, T ;

Tran, HT ;

Hu, WW ;

Blume, KG ;

Chow, DSL ;

Champlin, RE ;

Vaughan, WP .

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2000, 6 (5A) :548-554

[2] Conditioning therapy with intravenous busulfan and cyclophosphamide (IV BuCy2) for hematologic malignancies prior to allogeneic stem cell transplantation: A phase II study [J].

Andersson, BS ;

Kashyap, A ;

Gian, V ;

Wingard, JR ;

Fernandez, H ;

Cagnoni, PJ ;

Jones, RB ;

Tarantolo, S ;

Hu, WW ;

Blume, KG ;

Forman, SJ ;

Champlin, RE .

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2002, 8 (03) :145-154

[3] An evaluation of engraftment, toxicity and busulfan concentration in children receiving bone marrow transplantation for leukemia or genetic disease [J].

Bolinger, AM ;

Zangwill, AB ;

Slattery, JT ;

Glidden, D ;

DeSantes, K ;

Heyn, L ;

Risler, LJ ;

Bostrom, B ;

Cowan, MJ .

BONE MARROW TRANSPLANTATION, 2000, 25 (09) :925-930

[4] Prospective cohort study comparing intravenous busulfan to total body irradiation in hematopoietic cell transplantation [J].

Bredeson, Christopher ;

LeRademacher, Jennifer ;

Kato, Kazunobu ;

DiPersio, John F. ;

Agura, Edward ;

Devine, Steven M. ;

Appelbaum, Frederick R. ;

Tomblyn, Marcie R. ;

Laport, Ginna G. ;

Zhu, Xiaochun ;

McCarthy, Philip L. ;

Ho, Vincent T. ;

Cooke, Kenneth R. ;

Armstrong, Elizabeth ;

Smith, Angela ;

Rizzo, J. Douglas ;

Burkart, Jeanne M. ;

Pasquini, Marcelo C. .

BLOOD, 2013, 122 (24) :3871-3878

[5] MARROW TRANSPLANTATION FOR CHRONIC MYELOID-LEUKEMIA - A RANDOMIZED STUDY COMPARING CYCLOPHOSPHAMIDE AND TOTAL-BODY IRRADIATION WITH BUSULFAN AND CYCLOPHOSPHAMIDE [J].

CLIFT, RA ;

BUCKNER, CD ;

THOMAS, ED ;

BENSINGER, WI ;

BOWDEN, R ;

BRYANT, E ;

DEEG, HJ ;

DONEY, KC ;

FISHER, LD ;

HANSEN, JA ;

MARTIN, P ;

MCDONALD, GB ;

SANDERS, JE ;

SCHOCH, G ;

SINGER, J ;

STORB, R ;

SULLIVAN, KM ;

WITHERSPOON, RP ;

APPELBAUM, FR .

BLOOD, 1994, 84 (06) :2036-2043

[6] High busulfan exposure is associated with worse outcomes in a daily i.v. busulfan and fludarabine allogeneic transplant regimen [J].

Geddes, Michelle ;

Kangarloo, S. Bill ;

Naveed, Farrukh ;

Quinlan, Diana ;

Chaudhry, M. Ahsan ;

Stewart, Douglas ;

Savoie, M. Lynn ;

Bahlis, Nizar J. ;

Brown, Christopher ;

Storek, Jan ;

Andersson, Borje S. ;

Russell, James A. .

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2008, 14 (02) :220-228

[7] Intravenous versus oral busulfan as part of a busulfan/cyclophosphamide preparative regimen for allogeneic hematopoietic stem cell transplantation: Decreased incidence of hepatic venoocclusive disease (HVOD), HVOD-related mortality, and overall 100-day mortality [J].

Kashyap, A ;

Wingard, J ;

Cagnoni, P ;

Jones, R ;

Tarantolo, S ;

Hu, W ;

Blume, K ;

Niland, J ;

Palmer, JM ;

Vaughan, W ;

Fernandez, H ;

Champlin, R ;

Forman, S ;

Andersson, BS .

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2002, 8 (09) :493-500

[8] Comparison of Intravenous with Oral Busulfan in Allogeneic Hematopoietic Stem Cell Transplantation with Myeloablative Conditioning Regimens for Pediatric Acute Leukemia [J].

Kato, Motohiro ;

Takahashi, Yoshiyuki ;

Tomizawa, Daisuke ;

Okamoto, Yasuhiro ;

Inagaki, Jiro ;

Koh, Katsuyoshi ;

Ogawa, Atsushi ;

Okada, Keiko ;

Cho, Yuko ;

Takita, Junko ;

Goto, Hiroaki ;

Sakamaki, Hisashi ;

Yabe, Hiromasa ;

Kawa, Keisei ;

Suzuki, Ritsuro ;

Kudo, Kazuko ;

Kato, Koji .

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2013, 19 (12) :1690-1694

[9] Allogeneic Hematopoietic Stem-Cell Transplantation for Acute Myeloid Leukemia in Remission: Comparison of Intravenous Busulfan Plus Cyclophosphamide (Cy) Versus Total-Body Irradiation Plus Cy As Conditioning Regimen-A Report From the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation [J].

Nagler, Arnon ;

Rocha, Vanderson ;

Labopin, Myriam ;

Unal, Ali ;

Ben Othman, Tarek ;

Campos, Antonio ;

Volin, Liisa ;

Poire, Xavier ;

Aljurf, Mahmoud ;

Masszi, Tamas ;

Socie, Gerard ;

Sengelov, Henrik ;

Michallet, Mauricette ;

Passweg, Jakob ;

Veelken, Hendrik ;

Yakoub-Agha, Ibrahim ;

Shimoni, Avichai ;

Mohty, Mohamad .

JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (28) :3549-+

[10] Cyclophosphamide followed by Intravenous Targeted Busulfan for Allogeneic Hematopoietic Cell Transplantation: Pharmacokinetics and Clinical Outcomes [J].

Rezvani, Andrew R. ;

McCune, Jeannine S. ;

Storer, Barry E. ;

Batchelder, Ami ;

Kida, Aiko ;

Deeg, H. Joachim ;

McDonald, George B. .

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2013, 19 (07) :1033-1039

← 1 2 →